Inveready is a leading asset manager in Spain, investing in early-stage technology-based companies.
Inveready currently invests through 4 verticals (Venture Capital in Digital Technology, Venture Capital in Life Sciences, Venture Debt, and Hybrid Financing for quoted companies in growth markets), with more than €400M of assets under management.
Pablo de la Riva
“The future of anti-fraud stands that all threats can’t be controlled, and fraudsters can’t be identified. Buguroo makes sure that the world can enjoy the online experience while being protected under the safest environment.”
“AI will be a key support tool for medical specialists which will improve the quality of diagnosis and increase productivity. At Atrys, we are committed to keeping healthcare sustainable by using innovation and aim to be the company that leads precision healthcare diagnostic services and advanced radiotherapy treatments in Southern Europe and LATAM.”
Albert Castells & José López
“The Venture Debt option for iSalud allowed us to retain a large part of the value generated with the financing. iSalud is a clear case of Venture Debt being a perfect option for business models with recurrent revenues streams and favorable LTV/CAC ratios.”
“Thanks to the support of the Spanish Capital Market, MASMOVIL has gone from being a start-up to becoming the 4th telecommunications operator in Spain, with more than 8 million customers, as well as part of IBEX 35 in only 13 years of existence.”
“This is a busy and exciting time for Edesa. Our upcoming Phase 2b study of EB01 supports our goal to develop therapies for large, underserved patient populations, particularly in conditions where current treatments have serious limitations or side effects.”
“Joining the Spanish Alternative Market (MAB) boosted VozTelecom to become a leader in the Spanish cloud communications market.”
“Your intuition and our platform make your business decisions safer and smarter. Zinklar brings consumers to the heart of your decisions.”
“ODILO is the leading solution for intelligent digital libraries. Our mission is promoting educational equality by making high-quality digital content accessible and affordable to everyone.”
“Having a VC help us validate our business model by demonstrating that we can reach interesting exit scenarios and sign licensing agreements with pharmaceutical multinationals without the need for mega financing rounds has been crucial for us.”